Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Callaway

Showing results (51-60 of 124) with videos related to

Pageof 13
Sort By:
Psychopharmacology|January 1, 1985
Effects of oral scopolamine on human stimulus evaluationE Callaway, R Halliday, H Naylor, et al.
The European Physical Journal. E, Soft Matter|July 26, 2013
Nanoscale protein dynamics: a new frontier for neutron spin echo spectroscopyDavid J E Callaway, Bela Farago, Zimei Bu
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1991
Clonidine and scopolamine: differences and similarities in how they change human information processingE Callaway, R Halliday, H Naylor, et al.
Journal of Molecular Biology|July 14, 2009
Ezrin induces long-range interdomain allostery in the scaffolding protein NHERF1Jianquan Li, David J E Callaway, Zimei Bu
Psychopharmacology Bulletin|October 1, 1982
How does methylphenidate (MP) affect information processing in man?E Callaway, R Halliday, S Peeke, et al.
Electroencephalography and Clinical Neurophysiology. Supplement|January 1, 1987
Stimulus intensity, contrast, and complexity have additive effects on P300 latencyP Walton, E Callaway, R Halliday, et al.
Biochemistry|May 21, 1985
Contact site of histones 2A and 2B in chromatin and in solutionJ E Callaway, R J DeLange, H G Martinson
Seminars in Cutaneous Medicine and Surgery|July 28, 2001
Botulinum toxin type B: an overview of its biochemistry and preclinical pharmacologyJ E Callaway, J C Arezzo, A J Grethlein
Psychophysiology|September 1, 1976
Averaged evoked potential predictors of clinical improvement in hyperactive children treated with methylphenidate: an initial study and replicationR Halliday, J H Rosenthal, H Naylor, et al.
Disease-A-Month : DM|August 27, 2002
Botulinum toxin type B: an overview of its biochemistry and preclinical pharmacologyJames E Callaway, Joseph C Arezzo, Andrew J Grethlein
Pageof 13

Showing results (51-60 of 124) with videos related to

Sort By:
Pageof 13
Psychopharmacology|January 1, 1985
Effects of oral scopolamine on human stimulus evaluationE Callaway, R Halliday, H Naylor, et al.
The European Physical Journal. E, Soft Matter|July 26, 2013
Nanoscale protein dynamics: a new frontier for neutron spin echo spectroscopyDavid J E Callaway, Bela Farago, Zimei Bu
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1991
Clonidine and scopolamine: differences and similarities in how they change human information processingE Callaway, R Halliday, H Naylor, et al.
Journal of Molecular Biology|July 14, 2009
Ezrin induces long-range interdomain allostery in the scaffolding protein NHERF1Jianquan Li, David J E Callaway, Zimei Bu
Psychopharmacology Bulletin|October 1, 1982
How does methylphenidate (MP) affect information processing in man?E Callaway, R Halliday, S Peeke, et al.
Electroencephalography and Clinical Neurophysiology. Supplement|January 1, 1987
Stimulus intensity, contrast, and complexity have additive effects on P300 latencyP Walton, E Callaway, R Halliday, et al.
Biochemistry|May 21, 1985
Contact site of histones 2A and 2B in chromatin and in solutionJ E Callaway, R J DeLange, H G Martinson
Seminars in Cutaneous Medicine and Surgery|July 28, 2001
Botulinum toxin type B: an overview of its biochemistry and preclinical pharmacologyJ E Callaway, J C Arezzo, A J Grethlein
Psychophysiology|September 1, 1976
Averaged evoked potential predictors of clinical improvement in hyperactive children treated with methylphenidate: an initial study and replicationR Halliday, J H Rosenthal, H Naylor, et al.
Disease-A-Month : DM|August 27, 2002
Botulinum toxin type B: an overview of its biochemistry and preclinical pharmacologyJames E Callaway, Joseph C Arezzo, Andrew J Grethlein
Pageof 13